scientifyRESEARCH
research funding database

RESEARCH FUNDING

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis (China)

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis research grant from Pfizer seeks to generate new real-world evidence (RWE) to demonstrate the value of standardized diagnosis and treatment of atopic dermatitis. Research initiatives to be supported should be focused on evaluating the clinical values with quality control index tailored diagnosis and treatment in adolescent and adult patients with moderate-to-severe atopic dermatitis in real world settings. Applications are open to researchers at research institutions in China. The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

Applicants may apply for up to 100,000 USD for 1 year (including 28% indirect costs).

Applications are due on July 8, 2024.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
scientifyRESEARCH
monthly funding newsletter

unsubscribe at any time